Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Dicerna Pharmaceuticals, Inc. (DRNA)

« Back to company index

DRNA Chatter Timeline

Stock Ticker for DRNA

Most Active Tweeters for DRNA

UserTweets
@Tickeron 5
@newsfilterio 4
@EngineerTree5 3
@stock_titan 2
@StockNewsBot2 2

Recent Tweets for DRNA

formwhisperscom @formwhisperscom
#FWSells $DRNA Brown Bob D, Chief Scientific Ofr., EVP R&D of Dicerna Pharmaceuticals Inc sold 8,312 shares on 2021… https://t.co/YOkVjFn8ac
3:08am
joetrader87 @joetrader87
Looking for Fundamental and TA on $ALNY and $DRNA competitor Arrowhead Pharma? https://t.co/ngQPmyXPqa
August 4th 2021, 6:08pm
fintel_io @fintel_io
Insider Bob D Brown reports selling 8,312 shares of $DRNA for a total cost of $310,677.62 https://t.co/glLrpbIqBp
August 3rd 2021, 8:08pm
scottjo88508204 @scottjo88508204
@RNAiAnalyst enterprise valuation of $DRNA is better than $TBIO
August 3rd 2021, 1:08pm
newsfilterio @newsfilterio
Dicerna to Report Second Quarter 2021 Financial Results on Aug. 9, 2021 $DRNA https://t.co/0WKUwWu5tA
August 3rd 2021, 3:08am
StockNewsBot2 @StockNewsBot2
$DRNA Dicerna to Report Second Quarter 2021 Financial Results on Aug. 9, 2021 https://t.co/iBstjX1MN0
August 2nd 2021, 8:08pm
stock_titan @stock_titan
$DRNA Dicerna to Report Second Quarter 2021 Financial Results on Aug. 9, 2021 https://t.co/G5LvlOuG0k
August 2nd 2021, 8:08pm
FlashAlert_me @FlashAlert_me
$DRNA [15s. delayed]: Issued Press Release on August 02, 16:05:00: Dicerna to Report Second Quarter 2021 Financial… https://t.co/hfRMaOxjT1
August 2nd 2021, 8:08pm
quantisnow @quantisnow
$DRNA ? Dicerna to Report Second Quarter 2021 Financial Results on Aug. 9, 2021 https://t.co/pEFvm13fCn 30s delay… https://t.co/nAbqNaYmp2
August 2nd 2021, 8:08pm
Tickeron @Tickeron
$DRNA in Uptrend: Stochastic indicator peaks and leaves oversold zone. View odds for this and other indicators:… https://t.co/gKTEdIJYn6
July 31st 2021, 9:07pm
ChartMill @ChartMill
$DRNA was analyzed by 7 analysts. The buy consensus is at 100%. So analysts seem to be very confident about $DRNA.… https://t.co/tEe1mKCcb1
July 31st 2021, 5:07pm
Tickeron @Tickeron
$DRNA enters an Uptrend because Momentum Indicator exceeded the 0 level on July 29, 2021. View odds for this and ot… https://t.co/t8Im8vZDW8
July 30th 2021, 8:07pm
EngineerTree5 @EngineerTree5
$DRNA Progress is coming right along. Going to link to a podcast from 2018... listen to what the CEO was saying… https://t.co/RpG9drf6wY
July 30th 2021, 5:07pm
QuantchaIdeas @QuantchaIdeas
Covered Call Alert: DICERNA PHARMACEUTICALS INC. $DRNA returning up to 28.21% through 21-Jan-2022 https://t.co/sbwcpJKEOy
July 29th 2021, 4:07pm
SmallCapsDaily @SmallCapsDaily
$DRNA Dicerna Announces FDA Clearance of Investigational New Drug (IND) Application for DCR-AUD for the Treatment o… https://t.co/t5OlxZx3UF
July 29th 2021, 3:07pm
IOInvestors @IOInvestors
FDA Clears Dicerna Pharmaceuticals $DRNA Investigational New Drug (IND) Application for DCR-AUD for Alcohol Use Dis… https://t.co/5s6qrw5lMp
July 29th 2021, 3:07pm
bret_jensen @bret_jensen
Commented on $DRNA - Diving Into Dicerna Pharmaceuticals. https://t.co/LQtDmsviuJ
July 29th 2021, 2:07pm
Briefingcom @Briefingcom
$DRNA: Dicerna Pharmaceuticals announces FDA clearance of IND application for DCR-AUD as treatment for alcohol use.… https://t.co/A8KuKqcYrr
July 29th 2021, 1:07pm
GapUp4 @GapUp4
$DRNA FDA clears Dicerna's alcohol use disorder treatment DCR-AUD IND
July 29th 2021, 1:07pm
sbwcws @sbwcws
Dicerna receives FDA Clearance for DCR-AUD $DRNA
July 29th 2021, 1:07pm
mehabecapital @mehabecapital
$DRNA @ 37.30 - FDA clears Dicerna's alcohol use disorder treatment DCR-AUD IND https://t.co/a0Pxl7aoQh
July 29th 2021, 11:07am
newsfilterio @newsfilterio
FDA clears Dicerna's alcohol use disorder treatment DCR-AUD IND $DRNA https://t.co/uFkf29J1K8
July 29th 2021, 11:07am
FlashAlert_me @FlashAlert_me
$DRNA [15s. delayed]: Issued Press Release on July 29, 07:30:00: Dicerna Announces FDA Clearance of Investigational… https://t.co/zW77UrA4yr
July 29th 2021, 11:07am
StockNewsBot2 @StockNewsBot2
$DRNA Dicerna Announces FDA Clearance of Investigational New Drug (IND) Application for DCR-AUD for the Treatment o… https://t.co/yNSPosBeCv
July 29th 2021, 11:07am
stock_titan @stock_titan
$DRNA Dicerna Announces FDA Clearance of Investigational New Drug (IND) Application for DCR-AUD for the Treatment o… https://t.co/g4Uscyr3zr
July 29th 2021, 11:07am
mikalche @mikalche
$DRNA Dicerna Announces FDA Clearance of Investigational New Drug (IND) Application for DCR-AUD for the Treatment of Alcohol Use Disorder
July 29th 2021, 11:07am
robenneriah @robenneriah
Leerink's analyst Mani Foroohar maintained buy rating on Dicerna Pharma $DRNA. 2021-07-28
July 28th 2021, 12:07pm
TortozaLeandro @TortozaLeandro
$DRNA Awaiting Buy signal, https://t.co/k3k2H9mEa4
July 27th 2021, 10:07pm
Tickeron @Tickeron
A.I.dvisor is predicting $DRNA is about to fall. View odds of downtrend. #DicernaPharmaceuticals #stockmarket… https://t.co/Ovh3twrTOF
July 26th 2021, 3:07pm
ShortAlgoTrades @ShortAlgoTrades
$DRNA Awaiting buy signal on DRNA https://t.co/LGDIA85wrv
July 26th 2021, 11:07am
Tickeron @Tickeron
$DRNA in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/ZddHLvh880
July 26th 2021, 4:07am
BikeRieder @BikeRieder
RT @humour_humourrr: @gamechangercap There were multiple setbacks in RNAi field. It's not unheard of. $arwr $drna https://t.co/INpoMb67Pg
July 25th 2021, 9:07pm
gamechangercap @gamechangercap
@humour_humourrr That’s $drna ‘s entire market cap right now for one asset
July 25th 2021, 5:07pm
humour_humourrr @humour_humourrr
@gamechangercap There were multiple setbacks in RNAi field. It's not unheard of. $arwr $drna https://t.co/INpoMb67Pg
July 25th 2021, 5:07pm
Tickeron @Tickeron
$DRNA in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/2AOIoSOQSc
July 24th 2021, 8:07pm
EngineerTree5 @EngineerTree5
@AnthonyOhayon Can you do $DRNA $AMRS ? I see you like TWST and FLGT so won’t ask for those. But the former two I’m… https://t.co/calrguDiip
July 24th 2021, 4:07pm
EngineerTree5 @EngineerTree5
Mobile charting... $DRNA about to breakout from a 6 year high? Fact or fiction??? This company is on the rise and p… https://t.co/qrmVrm3901
July 24th 2021, 3:07pm
sonichedgefund @sonichedgefund
$DRNA is like teflon. Convinced the S-3 has already been drafted & the underwriters have their hooks in this around… https://t.co/F4BtC2OYQu
July 23rd 2021, 3:07pm
FinancialAdvBot @FinancialAdvBot
Entry point for $DRNA! ? https://t.co/5ZsShc17KX
July 23rd 2021, 3:07am
miojk7 @miojk7
$DRNA may manipulate its earnings. Its discretionary accruals in recent quarters are extremely larger.
July 22nd 2021, 3:07pm
FrankHulskof @FrankHulskof
@BayAreaBiotechI @MarkC_LVB $DRNA is biting the dust, in time and performance. It's AATD program I guess will be mo… https://t.co/WPCylh11kV
July 22nd 2021, 8:07am
newsfilterio @newsfilterio
Dicerna posts interim results from early-stage belcesiran liver disease trial $DRNA https://t.co/sTScogyIsD
July 22nd 2021, 4:07am
newsfilterio @newsfilterio
Dicerna Posts Updated Data From Belcesiran Early-Stage Study For Genetic Liver Disease $DRNA https://t.co/N0rYbI9htR
July 22nd 2021, 4:07am
MarcJacksonLA @MarcJacksonLA
$DRNA Dicerna Announces Interim Results From Phase 1 Trial of Belcesiran for Treatment of Alpha-1 Antitrypsin Defic… https://t.co/2kkYOCORtE
July 22nd 2021, 1:07am
MarkC_LVB @MarkC_LVB
@BayAreaBiotechI Your tweet said $ARWR & $DRNA results comparable, now the N=4 in DRNA study is too small for concl… https://t.co/UfcS6RFX39
July 22nd 2021, 12:07am
newsfilterio @newsfilterio
Dicerna slips from peak after data for liver disease trial; RBC analyst shrugs off impact $DRNA https://t.co/twK3FslQOH
July 21st 2021, 10:07pm
mehabecapital @mehabecapital
$DRNA @ 38.50 - Dicerna slips from peak after data for liver disease trial; RBC analyst shrugs off impact https://t.co/FebSZgnbkR
July 21st 2021, 9:07pm
TradeWithAlerts @TradeWithAlerts
Large Print $DRNA Size: 142787 Price: 38.5 Time: 1612 Amount: $5,497,299.50 - Delayed - For real time prints subscr… https://t.co/LIHEZHg7JG
July 21st 2021, 8:07pm
MaisaCorp @MaisaCorp
$DRNA saying one of the patients with alpha-1 antitrypsin deficiency-associated liver disease participating in a ph… https://t.co/VYoNe6UiDX
July 21st 2021, 8:07pm
scottjo88508204 @scottjo88508204
@MarkC_LVB @BayAreaBiotechI Between the $DRNA and $ARWR, there will be many approvals. Plenty of room for both!
July 21st 2021, 4:07pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.